Published in Biomed Res Int on July 20, 2014
The Role of Overweight and Obesity in In Vitro Fertilization Outcomes of Poor Ovarian Responders. Biomed Res Int (2015) 1.09
Comparison Pregnancy Outcomes Between Minimal Stimulation Protocol and Conventional GnRH Antagonist Protocols in Poor Ovarian Responders. J Family Reprod Health (2016) 0.77
Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation. Pak J Med Sci (2016) 0.75
Optimal embryo transfer strategy in poor response may include freeze-all. J Assist Reprod Genet (2016) 0.75
Mid-luteal estradiol levels of poor/good responders and intracytoplasmic sperm injection. Pak J Med Sci (2017) 0.75
New Frontier in Glycoprotein Hormones and Their Receptors Structure-Function. Front Endocrinol (Lausanne) (2015) 0.75
The Ideal Stimulation Protocol: Is There One? J Obstet Gynaecol India (2015) 0.75
Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone. J Res Med Sci (2016) 0.75
Morphokinetic Characteristics and Developmental Potential of In Vitro Cultured Embryos from Natural Cycles in Patients with Poor Ovarian Response. Biomed Res Int (2016) 0.75
Poor ovarian reserve. J Hum Reprod Sci (2016) 0.75
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod (2011) 5.49
A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update (2006) 4.24
Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod (1992) 3.66
Low-dose aspirin for in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update (2007) 2.86
Mature oocyte cryopreservation: a guideline. Fertil Steril (2012) 2.61
Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders. Fertil Steril (1998) 2.57
The use of recombinant luteinizing hormone in patients undergoing assisted reproductive techniques with advanced reproductive age: a systematic review and meta-analysis. Fertil Steril (2012) 2.52
Serum anti-Mullerian hormone throughout the human menstrual cycle. Hum Reprod (2006) 2.37
Assisted conception following poor ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol (1997) 2.12
Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab (1996) 2.06
Cycle cancellation and pregnancy after luteal estradiol priming in women defined as poor responders: a systematic review and meta-analysis. Hum Reprod (2013) 2.04
Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev (2011) 2.03
Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest (1998) 2.00
The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril (1992) 1.98
Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a microdose follicle-stimulating hormone flare, growth hormone protocol. Fertil Steril (1997) 1.93
Young age does not protect against the adverse effects of reduced ovarian reserve--an eight year study. Hum Reprod (2002) 1.91
Anti-Müllerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod (2006) 1.87
A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril (2011) 1.85
Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod Biomed Online (2009) 1.80
High-dose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril (1996) 1.75
Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril (2000) 1.74
Primary ovarian insufficiency. Lancet (2010) 1.67
Is there a place for corifollitropin alfa in IVF/ICSI cycles? A systematic review and meta-analysis. Fertil Steril (2012) 1.66
Accumulation of oocytes: a new strategy for managing low-responder patients. Reprod Biomed Online (2012) 1.62
Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum Reprod (2012) 1.57
Economic consequences of overweight and obesity in infertility: a framework for evaluating the costs and outcomes of fertility care. Hum Reprod Update (2010) 1.55
Endometriosis and infertility: pathophysiology and management. Lancet (2010) 1.55
Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab (1999) 1.52
How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril (2008) 1.48
Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev (1985) 1.47
Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril (1998) 1.47
Androgen receptor gene expression in the primate ovary: cellular localization, regulation, and functional correlations. J Clin Endocrinol Metab (1998) 1.42
GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis. Reprod Biomed Online (2006) 1.37
Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy. Hum Reprod (2007) 1.33
Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril (1999) 1.32
The poor responder in IVF: is the prognosis always poor?: a systematic review. Hum Reprod Update (2011) 1.32
Comparison of 'poor' responders with 'good' responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod (1991) 1.26
Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod (2003) 1.25
Natural-cycle in vitro fertilization in poor responder patients: a survey of 500 consecutive cycles. Fertil Steril (2008) 1.22
Doubling the human menopausal gonadotrophin dose in the course of an in-vitro fertilization treatment cycle in low responders: a randomized study. Hum Reprod (1993) 1.21
Microdose follicular phase gonadotropin-releasing hormone agonist (GnRH-a) compared with luteal phase GnRH-a for ovarian stimulation at in vitro fertilization. Fertil Steril (1999) 1.20
Postmenopausal dehydroepiandrosterone administration increases free insulin-like growth factor-I and decreases high-density lipoprotein: a six-month trial. Fertil Steril (1998) 1.20
The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update (2012) 1.13
Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols? Hum Reprod (1999) 1.12
Low-dose aspirin in a short regimen as standard treatment in in vitro fertilization: a randomized, prospective study. Fertil Steril (2004) 1.10
The impact of excision of ovarian endometrioma on ovarian reserve: a systematic review and meta-analysis. J Clin Endocrinol Metab (2012) 1.10
Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod (2012) 1.10
Poor ovarian responders: to meta-analyse or not, that is the question. Hum Reprod (2014) 1.10
Management of poor responders in IVF. Reprod Biomed Online (2005) 1.09
Advanced reproductive age and fertility. J Obstet Gynaecol Can (2011) 1.08
Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum Reprod (2010) 1.08
Use of the flare-up protocol with high dose human follicle stimulating hormone and human menopausal gonadotropins for in vitro fertilization in poor responders. Fertil Steril (1996) 1.07
Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation. J Assist Reprod Genet (1996) 1.07
Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod (2010) 1.07
Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective randomized placebo-controlled double-blind study. Hum Reprod (1995) 1.07
Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization. Fertil Steril (1997) 1.04
Rate of severe ovarian damage following surgery for endometriomas. Hum Reprod (2010) 1.04
Effect of androgen levels on in vitro fertilization cycles. Fertil Steril (2004) 1.03
Anti-Mullerian hormone and inhibin B levels as markers of premature ovarian aging and transition to menopause in type 1 diabetes mellitus. Hum Reprod (2009) 1.03
Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle. Fertil Steril (1998) 1.03
A rational approach to the management of low responders in in-vitro fertilization. Hum Reprod (1999) 1.03
Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile? Hum Reprod (1999) 0.99
Addition of GnRH antagonist in cycles of poor responders undergoing IVF. Hum Reprod (2000) 0.98
Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol (Oxf) (1998) 0.98
Comparisons of GnRH antagonist versus GnRH agonist protocol in poor ovarian responders undergoing IVF. Hum Reprod (2011) 0.97
Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. Fertil Steril (2012) 0.97
Hopes and facts about mild ovarian stimulation. Reprod Biomed Online (2007) 0.96
Should androgen supplementation be used for poor ovarian response in IVF? Hum Reprod (2012) 0.96
Conception rates following assisted reproduction in poor responder patients: a retrospective study in 300 consecutive cycles. Reprod Biomed Online (2003) 0.95
High-dose follicle-stimulating hormone stimulation at the onset of the menstrual cycle does not improve the in vitro fertilization outcome in low-responder patients. Fertil Steril (1990) 0.93
Adjuvant growth hormone therapy in antagonist protocol in poor responders undergoing assisted reproductive technology. Arch Gynecol Obstet (2012) 0.93
Suppression and flare regimens of gonadotropin-releasing hormone agonist. Use in women with different basal gonadotropin values in an in vitro fertilization program. J Reprod Med (1996) 0.92
Assessment of ovarian and uterine blood flow by transvaginal color Doppler in ovarian-stimulated women: correlation with the number of follicles and steroid hormone levels. Fertil Steril (1993) 0.92
Live birth rates in Bologna poor responders treated with ovarian stimulation for IVF/ICSI. Reprod Biomed Online (2013) 0.92
Predicting poor ovarian response in IVF: use of repeat basal FSH measurement. J Reprod Med (2004) 0.91
High-dose follicle-stimulating hormone (FSH) ovarian stimulation in low-responder patients for in vitro fertilization. J In Vitro Fert Embryo Transf (1989) 0.91
High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial. Hum Reprod (2000) 0.91
Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study. Hum Reprod (2013) 0.91
What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil Steril (2009) 0.91
A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization. Hum Reprod (1994) 0.90
Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update (2009) 0.90
Low-dose aspirin use does not improve in vitro fertilization outcomes in poor responders. Fertil Steril (2007) 0.89
Recurrent implantation failure in assisted reproduction: how to counsel and manage. B. Treatment options that have not been proven to benefit the couple. Reprod Biomed Online (2005) 0.88
Direct effect of gonadotropin-releasing hormone agonists on the rabbit ovarian follicle. Fertil Steril (1992) 0.88
The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization. Hum Reprod (1997) 0.88
In women with endometriosis anti-Müllerian hormone levels are decreased only in those with previous endometrioma surgery. Hum Reprod (2012) 0.88
The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil Steril (1991) 0.88
Hypothalamic-pituitary ageing: progressive increase in FSH and LH concentrations throughout the reproductive life in regularly menstruating women. Clin Endocrinol (Oxf) (1994) 0.87
Pituitary suppression regimens in poor responders undergoing IVF treatment: a systematic review and meta-analysis. Reprod Biomed Online (2007) 0.87
Recombinant human follicle-stimulating hormone (r-hFSH) plus recombinant luteinizing hormone versus r-hFSH alone for ovarian stimulation during assisted reproductive technology: systematic review and meta-analysis. Reprod Biol Endocrinol (2014) 0.87
Aetiological factors involved in the low response to gonadotrophins in infertile women with normal basal serum follicle stimulating hormone levels. Hum Reprod (1994) 0.87
The Bologna criteria for poor ovarian response; has the job been accomplished? Hum Reprod (2012) 0.86
Specific insulin-like growth factor (IGF) I- and II-binding sites on rat granulosa cells: relation to IGF action. Endocrinology (1986) 0.86
Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology (1986) 0.85
Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril (2000) 0.85
Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality. J Assist Reprod Genet (2001) 0.84
In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab (1993) 0.84
Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization. Fertil Steril (1999) 0.84
Long-term effects of uterine fibroid embolization on ovarian reserve: a prospective cohort study. Fertil Steril (2010) 0.84
Loop electrosurgical excision procedure: a risk for spontaneous abortion? Fertil Steril (2015) 0.75